DK vs CLMT

For growth investors, Calumet, Inc.

(CLMT) is the stronger pick with 0. 2% revenue growth year-over-year, versus -9. 5% for Delek US Holdings, Inc. (DK). Analysts rate Delek US Holdings, Inc. (DK) a "Hold" — based on 26 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Calumet, Inc.

(CLMT) delivered a total return of +441. 6%, compared to +98. 1% for Delek US Holdings, Inc. (DK). Over 10 years, the gap is even starker: CLMT returned +743. 5% versus DK's +253. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Delek US Holdings, Inc.

(DK) is the lower-risk stock at 0. 33β versus Calumet, Inc. 's 0. 40β — meaning CLMT is approximately 22% more volatile than DK relative to the S&P 500.

By revenue growth (latest reported year), Calumet, Inc.

(CLMT) is pulling ahead at 0. 2% versus -9. 5% for Delek US Holdings, Inc. (DK). On earnings-per-share growth, the picture is similar: Delek US Holdings, Inc. grew EPS 95. 7% year-over-year, compared to -552. 5% for Calumet, Inc.. Over a 3-year CAGR, CLMT leads at 10. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Delek US Holdings, Inc.

(DK) is the more profitable company, earning -0. 2% net margin versus -5. 3% for Calumet, Inc. — meaning it keeps -0. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DK leads at 3. 7% versus 0. 2% for CLMT. At the gross margin level — before operating expenses — CLMT leads at 5. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Delek US Holdings, Inc.

(DK) trades at 11. 9x forward P/E versus 451. 0x for Calumet, Inc. — 439. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DK: -1. 5% to $44. 33.

In this comparison, DK (2.

3% yield) pays a dividend. CLMT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Delek US Holdings, Inc.

(DK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), 2. 3% yield, +253. 9% 10Y return). Both have compounded well over 10 years (DK: +253. 9%, CLMT: +743. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

DK pays a dividend while CLMT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.